Acadia Healthcare Stock Rises Above 200-Day Average

Shares of the mental health services provider reach a new high, but analysts are mixed on the stock's outlook.

Mar. 31, 2026 at 6:11am

Got story updates? Submit your updates here. ›

A highly detailed, cinematic close-up of the complex inner workings of a bank vault, conveying the secure and institutional nature of Acadia Healthcare's financial operations.An extreme close-up of the intricate machinery powering Acadia Healthcare's financial operations signals the company's institutional strength in the mental health services industry.Franklin Today

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rose above their 200-day moving average on Monday, trading as high as $23.40 before closing at $22.83. The stock has a 200-day moving average of $18.76. Acadia Healthcare is a provider of behavioral healthcare services with a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Why it matters

Crossing above the 200-day moving average is often seen as a bullish technical signal, indicating the stock may be in the midst of a longer-term uptrend. However, analysts have a mixed outlook on Acadia Healthcare, with some maintaining a 'buy' rating while others have lowered their price targets due to concerns about the company's performance.

The details

Acadia Healthcare shares have traded in a range of $14.19 to $27.00 over the past 52 weeks. The company reported earnings of $0.07 per share in its most recent quarter, beating analysts' expectations of $0.03 per share. Acadia has set its full-year 2026 earnings guidance at $1.30 to $1.55 per share.

  • Acadia Healthcare shares passed above their 200-day moving average on Monday, March 30, 2026.
  • The company reported Q4 2025 earnings on February 25, 2026.

The players

Acadia Healthcare Company, Inc.

A publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Acadia operates a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs across the United States.

Got photos? Submit your photos here. ›

What they’re saying

“We have a 'buy' rating on Acadia Healthcare, but have lowered our price target due to concerns about the company's performance.”

— Analyst

“Acadia Healthcare has set strong earnings guidance for fiscal year 2026, which could signal a turnaround for the company.”

— Analyst

What’s next

Investors will be closely watching Acadia Healthcare's upcoming quarterly earnings report to see if the company can maintain its momentum and meet or exceed its full-year guidance.

The takeaway

Acadia Healthcare's stock price crossing above its 200-day moving average is a positive technical signal, but the company's long-term outlook remains mixed according to Wall Street analysts. The mental health services provider's ability to execute on its growth strategy and financial targets will be key to determining the stock's future performance.